Table 2.
Demographic and Clinical Predictors of Benefit Finding
| |
Benefit finding score |
|
|
|---|---|---|---|
| Mean | SD | p-Value | |
| Age, years | 0.001 | ||
| ≤65 | 2.76 | 0.68 | |
| >65 | 2.49 | 0.60 | |
| Gender | 0.019 | ||
| Male | 2.56 | 0.62 | |
| Female | 2.75 | 0.68 | |
| Race/ethnicity | <0.001 | ||
| White | 2.60 | 0.66 | |
| Nonwhite* | 2.95 | 0.63 | |
| Educational Level | 0.179 | ||
| High school or less | 2.77 | 0.73 | |
| College or above | 2.65 | 0.64 | |
| Employment | 0.833 | ||
| Not employed | 2.67 | 0.69 | |
| Employed | 2.69 | 0.64 | |
| Cancer Type | 0.637 | ||
| Breast | 2.72 | 0.71 | - |
| GI | 2.73 | 0.66 | 0.966 |
| Lung | 2.61 | 0.64 | 0.274 |
| Other | 2.67 | 0.67 | 0.698 |
| Cancer Stage | 0.937 | ||
| Localized disease | 2.69 | 0.68 | |
| Metastatic disease | 2.68 | 0.66 | |
| Surgery | 0.114 | ||
| No | 2.61 | 0.65 | |
| Yes | 2.74 | 0.68 | |
| Radiation | 0.508 | ||
| No | 2.66 | 0.70 | |
| Yes | 2.71 | 0.63 | |
| Chemotherapy | 0.175 | ||
| No | 2.53 | 0.62 | |
| Yes | 2.70 | 0.67 | |
| Time since cancer diagnosis | 0.005 | ||
| ≤12 months | 2.56 | 0.70 | - |
| >12 and ≤36 months | 2.69 | 0.61 | 0.174 |
| >36 months | 2.86 | 0.61 | 0.001 |
| CAM use | 0.003 | ||
| No | 2.54 | 0.68 | |
| Yes | 2.77 | 0.64 | |
P-values in boldface type are statistically significant.
*
Mostly African American.